Akebia enters into term loan facility with Symbiotic Capital worth up to $140 million
AKBA•Akebia Therapeutics entered into a term loan facility with Symbiotic Capital worth up to $140 million, including a $60 million initial tranche and up to $80 million in an incremental tranche.
1. Loan facility
Akebia Therapeutics entered into a term loan facility with Symbiotic Capital worth up to $140 million. The facility includes a $60 million initial tranche and up to $80 million in an incremental tranche.




